Get all your news in one place.
100's of premium titles.
One app.
Start reading
Fortune
Fortune
Anna Heim

German medical cannabis companies aren't coming down from their high—they‘re predicted to bring in $1 billion in sales by 2028

(Credit: Ferreira/Bloomberg via Getty Images)

Germany’s “traffic light” coalition is no more; but when it comes to cannabis, its legacy is here to stay. Since April 1, 2024 and for the foreseeable future, doctors can now prescribe it, creating tailwinds for the country’s medical cannabis startups.

North American players took notice. In June of this year, NASDAQ-listed cannabis producer Organigram Holdings invested in Berlin-based cannabis company Sanity Group with hopes of gaining a foothold in what it sees as a high-growth market.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.